These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 10791032

  • 1. [Apomorphine in treatment of Parkinson's disease with fluctuations].
    Zaleska B, Domzał T.
    Neurol Neurochir Pol; 1999; 33(6):1297-303. PubMed ID: 10791032
    [Abstract] [Full Text] [Related]

  • 2. [Apomorphine for treatment of "off-periods" in Parkinson's disease].
    Zoldan J, Merims D, Kuritzky A, Ziv I, Melamed E.
    Harefuah; 1999 Nov 15; 137(10):444-6, 512, 511. PubMed ID: 10959339
    [Abstract] [Full Text] [Related]

  • 3. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
    Deleu D, Hanssens Y, Northway MG.
    Drugs Aging; 2004 Nov 15; 21(11):687-709. PubMed ID: 15323576
    [Abstract] [Full Text] [Related]

  • 4. [Apomorphine in off state--clinical experience].
    Rudzińska M, Szczudlik A.
    Neurol Neurochir Pol; 2007 Nov 15; 41(2 Suppl 1):S40-8. PubMed ID: 17941458
    [Abstract] [Full Text] [Related]

  • 5. [Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].
    Rambour M, Moreau C, Salleron J, Devos D, Kreisler A, Mutez E, Simonin C, Annic A, Dujardin K, Destée A, Defebvre L.
    Rev Neurol (Paris); 2014 Mar 15; 170(3):205-15. PubMed ID: 24594365
    [Abstract] [Full Text] [Related]

  • 6. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ, Obering C.
    Clin Ther; 2005 Nov 15; 27(11):1710-24. PubMed ID: 16368444
    [Abstract] [Full Text] [Related]

  • 7. Apomorphine in patients with Parkinson's disease.
    Muguet D, Broussolle E, Chazot G.
    Biomed Pharmacother; 1995 Nov 15; 49(4):197-209. PubMed ID: 7669939
    [Abstract] [Full Text] [Related]

  • 8. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
    Manson AJ, Turner K, Lees AJ.
    Mov Disord; 2002 Nov 15; 17(6):1235-41. PubMed ID: 12465062
    [Abstract] [Full Text] [Related]

  • 9. [Subcutaneous apomorphine infusion in the treatment of Parkinson disease].
    Albani C, Zangger I, Fischer G.
    Schweiz Rundsch Med Prax; 1992 Aug 25; 81(35):1011-5. PubMed ID: 1410978
    [Abstract] [Full Text] [Related]

  • 10. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
    Katzenschlager R, Hughes A, Evans A, Manson AJ, Hoffman M, Swinn L, Watt H, Bhatia K, Quinn N, Lees AJ.
    Mov Disord; 2005 Feb 25; 20(2):151-7. PubMed ID: 15390035
    [Abstract] [Full Text] [Related]

  • 11. [Apomorphine: an alternative in the control of motor fluctuations in Parkinson's disease].
    Ferraz HB, Azevedo-Silva SM, Borges V, Rocha MS, Andrade LA.
    Arq Neuropsiquiatr; 1995 Jun 25; 53(2):245-51. PubMed ID: 7487531
    [Abstract] [Full Text] [Related]

  • 12. Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease.
    Obering CD, Chen JJ, Swope DM.
    Pharmacotherapy; 2006 Jun 25; 26(6):840-52. PubMed ID: 16716137
    [Abstract] [Full Text] [Related]

  • 13. Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.
    Pietz K, Hagell P, Odin P.
    J Neurol Neurosurg Psychiatry; 1998 Nov 25; 65(5):709-16. PubMed ID: 9810943
    [Abstract] [Full Text] [Related]

  • 14. Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?
    Montastruc JL, Rascol O, Senard JM, Houin G, Rascol A.
    J Neural Transm Suppl; 1995 Nov 25; 45():157-61. PubMed ID: 8748621
    [Abstract] [Full Text] [Related]

  • 15. [Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease].
    Pollak P, Champay AS, Gaio JM, Hommel M, Benabid AL, Perret J.
    Rev Neurol (Paris); 1990 Nov 25; 146(2):116-22. PubMed ID: 2320817
    [Abstract] [Full Text] [Related]

  • 16. Apomorphine: an underutilized therapy for Parkinson's disease.
    Poewe W, Wenning GK.
    Mov Disord; 2000 Sep 25; 15(5):789-94. PubMed ID: 11009181
    [Abstract] [Full Text] [Related]

  • 17. [Subcutaneous apomorphine in the treatment of Parkinson's disease].
    Linazasoro G.
    Neurologia; 1994 Jan 25; 9(1):1-3. PubMed ID: 8161461
    [Abstract] [Full Text] [Related]

  • 18. Subcutaneous apomorphine in parkinsonian on-off oscillations.
    Stibe CM, Lees AJ, Kempster PA, Stern GM.
    Lancet; 1988 Feb 20; 1(8582):403-6. PubMed ID: 2893200
    [Abstract] [Full Text] [Related]

  • 19. Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.
    van Laar T, Postma AG, Drent M.
    Parkinsonism Relat Disord; 2010 Jan 20; 16(1):71-2. PubMed ID: 19524477
    [No Abstract] [Full Text] [Related]

  • 20. [Apomorphine in the treatment of Parkinson's Disease].
    Dressler D.
    Nervenarzt; 2005 Jun 20; 76(6):681-9. PubMed ID: 15592807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.